Vivos Therapeutics, Inc. VVOS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

56/100

3/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para Vivos Therapeutics, Inc. (VVOS), incluyendo 41 compras y 6 ventas. El total de compras internas fue valorado en $5.18M y el total de ventas internas en $1.05M.

Internos destacados con actividad reciente incluyen Skaff Michael C, Johnson Gregg C, Amman Bradford K.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — VVOS

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-03-31	Skaff Michael C	10 Percent Owner	Compra Informativa	429,957	$0.00	$43.00	429,957
2026-02-04	Johnson Gregg C	Director	Desconocido	-	-	-	3,997
2025-06-09	Skaff Michael C	10 Percent Owner	Desconocido	725,258	$0.00	$72.53	-
2024-11-26	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	149,533	$2.64	$394.77K	180,533
2024-11-26	Huntsman Ronald Kirk	Chief Executive Officer	Concesión de RSU	315,421	$2.64	$832.71K	364,755
2024-06-20	Sokolow Leonard J	Director	Concesión de RSU	4,000	$2.38	$9.52K	7,467
2024-06-20	Krammer Anja B	Director	Concesión de RSU	4,000	$2.38	$9.52K	7,067
2024-06-20	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	15,000	$2.38	$35.7K	31,667
2024-06-20	Thompson Matthew	Director	Concesión de RSU	4,000	$2.38	$9.52K	7,067
2024-06-20	Huntsman Ronald Kirk	Chief Executive Officer	Concesión de RSU	20,000	$2.38	$47.6K	49,334
2024-06-20	Lindsay Mark F.	Director	Concesión de RSU	4,000	$2.38	$9.52K	7,067
2024-06-20	Green Ralph Elias	Director	Concesión de RSU	4,000	$2.38	$9.52K	7,067
2024-06-10	Skaff Michael C	10 Percent Owner	Desconocido	3,220,266	$2.20	$7.1M	-
2023-06-20	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	14,000	$0.53	$7.42K	86,521
2023-06-16	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	10,000	$0.54	$5.4K	67,521
2023-06-15	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	21	$0.50	$10.50	57,521
2023-06-14	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	10,000	$0.49	$4.9K	57,500
2022-12-23	Sokolow Leonard J	Director	Concesión de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Krammer Anja B	Director	Concesión de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	200,000	$0.48	$96K	500,001
2022-12-23	Thompson Matthew	Director	Concesión de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	20,000	$0.50	$10K	47,500
2022-12-23	Lindsay Mark F.	Director	Concesión de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Green Ralph Elias	Director	Concesión de RSU	30,000	$0.48	$14.4K	76,667
2022-05-31	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	8,000	$2.03	$16.24K	23,500
2022-02-25	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	50,000	$3.27	$163.5K	50,000
2022-02-25	Huntsman Ronald Kirk	Chief Executive Officer	Concesión de RSU	125,000	$3.27	$408.75K	125,000
2021-09-21	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	5,000	$4.31	$21.55K	15,500
2021-08-31	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	50,000	$5.26	$263K	50,000
2021-08-17	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	5,000	$3.00	$15K	10,500
2021-08-05	Sokolow Leonard J	Director	Concesión de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Krammer Anja B	Director	Concesión de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Thompson Matthew	Director	Concesión de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Singh Gurdev Dave	10 Percent Owner, Officer: Chief Medical Officer	Concesión de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Lindsay Mark F.	Director	Concesión de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Green Ralph Elias	Director	Concesión de RSU	30,000	$2.72	$81.6K	46,667
2021-06-16	Huntsman Ronald Kirk	Chief Executive Officer	Concesión de RSU	125,000	$5.64	$705K	125,000
2021-05-25	Amman Bradford K.	Chief Financial Officer	Compra Informativa	1,000	$5.29	$5.29K	2,000
2021-05-25	Huntsman Ronald Kirk	Chief Executive Officer	Compra Informativa	4,000	$5.38	$21.52K	5,500
2021-03-12	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	100,000	$7.50	$750K	100,000
2021-03-12	Amman Bradford K.	Chief Financial Officer	Concesión de RSU	100,000	$7.50	$750K	200,001
2020-12-24	Amman Bradford K.	Chief Financial Officer	Compra Informativa	1,000	$7.38	$7.38K	1,000
2020-12-23	Huntsman Ronald Kirk	10 Percent Owner, Officer: Chief Executive Officer	Compra Informativa	1,000	$7.27	$7.27K	1,500
2020-12-11	Huntsman Ronald Kirk	10 Percent Owner, Officer: Chief Executive Officer	Compra Informativa	500	$8.50	$4.25K	500
2020-12-10	Sokolow Leonard J	Director	Disposición	16,667	$7.50	$125K	-
2020-12-10	Krammer Anja B	Director	Disposición	16,667	$7.50	$125K	-
2020-12-10	Amman Bradford K.	Chief Financial Officer	Disposición	16,667	$7.50	$125K	-
2020-12-10	Thompson Matthew	Director	Disposición	16,667	$7.50	$125K	-
2020-12-10	Huntsman Ronald Kirk	10 Percent Owner, Officer: Chairman & CEO	Disposición	333,334	$1.65	$550K	-
2020-12-10	Singh Gurdev Dave	10 Percent Owner, Officer: Chief Medical Officer	Disposición	-	-	-	700,000

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento